INTRODUCTION
============

Worldwide, infections cause 40% of the estimated 1.6 million neonatal deaths each year[@B1] ^,^ [@B2]. Blood cultures are the gold standard of diagnosis but positivity is particularly low in neonates[@B3]. Factors such as only one blood culture performed per infection episode, blood collection performed in only one site, delayed entry of culture bottles into machines and mainly the low blood volumes inserted into culture bottles[@B4] ^--^ [@B6] are associated with this low positivity[@B7] ^--^ [@B9].

Given the potentially severe sequelae of neonatal infections, the myriad of presentations of neonatal sepsis and the limitations of blood culture sensitivity, culture-negative sepsis (clinical sepsis), has long been accepted as a diagnosis in neonatal intensive care units. This diagnosis has persisted due to the presumption that neonatologists are able to recognize infected neonates even though signs/symptoms are not specific. In addition, several reports have shown that neonates with blood culture-positive or culture-negative sepsis will present higher rates of neurodevelopmental impairment compared to non-infected infants, emphasizing the need to better characterize these blood culture-negative cases[@B10].

Opposing these ideas, in a recent report, the authors have criticized the skepticism to trust blood culture results, especially when they are negative in suspected cases of neonatal sepsis. They questioned the unintended harm caused by prolonged or unnecessary use of antibiotics which expose infants to an increased risk of obesity, atopy and, for preterm infants, to necrotizing enterocolitis, bronchopulmonary dysplasia, sepsis and death. However, these authors have made it clear that reliability of blood culture results depends on the application of correct blood collection techniques, the use of appropriate culture bottles, the rapid referral of samples to the laboratory and in particular, the use of adequate blood volumes[@B11].

In recent years, quantitative Polymerase Chain Reaction amplification (qPCR) has proved to be more sensitive than blood culture and conventional PCR, determining the load of microorganisms and releasing faster results. The time required for the final release of positive cultures varies from 24 to 72 h, while the release of negative results takes much longer, approximately five days. This is the main factor that makes neonates with an initial suspicion of infection to receive antibiotics for at least five days, increasing the risks of infections associated with health care. This extended amount of time of blood culture results contrasts with that of qPCR, which can release positive or negative results within 24 h[@B12] ^--^ [@B14].

The aim of the present study was to assess and compare bacterial load levels determined by qPCR in culture-positive and culture-negative cases of neonatal sepsis. Bacterial load levels were analyzed with respect to clinical and laboratory findings.

MATERIAL AND METHODS
====================

Neonates and their mothers
--------------------------

This research was approved by the Research Ethics Committee of the participating institutions (CAPPesq process N° 0889/09 and 587/CEP-HUJM/08). Neonates were from three neonatal intensive care units (NICUs) of public tertiary care hospitals: Federal University of Mato Grosso, Cuiaba, Mato Grosso (10 beds); Santa Helena Hospital, Cuiaba, Mato Grosso (20 beds) and the Children\'s Institute, University of Sao Paulo, Sao Paulo (20 beds).

This is a prospective cohort study of neonates with symptomatology and laboratory exams indicative of sepsis, randomized according to blood cultures results (positive or negative).

Mothers
-------

Regarding the mothers, demographic data such as age, prenatal care, parity, type of delivery, diseases during pregnancy and use of antibiotics were retrieved from medical records.

Inclusion criteria of neonates
------------------------------

Neonates had to present at least two signs/symptoms suggestive of infection[@B15] associated with at least two abnormal laboratory parameters in the complete blood count and C-Reactive Protein (CRP) analyses. The reference values to consider the parameters abnormal were leukocytosis (\> 20,000/mm^3^), leukopenia (\< 5,000/mm^3^), neutrophilia (\> 13,000/mm^3^), neutropenia (\< 1,000/mm^3^), neutrophil index \> 0.2 (immature neutrophil count/total), thrombocytopenia (\< 100,000/mm^3^), and CRP \> 10 mg/mL[@B16] ^,^ [@B17].

Exclusion criteria of neonates
------------------------------

Exclusion criteria were surgical procedures, presence of severe perinatal asphyxia defined by an Apgar score of less than 4 at 5 min of life[@B18], presence of congenital malformation or congenital infections.

Blood sampling and blood culture
--------------------------------

Blood sampling was performed at the time of admission to the neonatal intense care unit (NICU) before the initiation of antibiotics. The recommendation adopted in the study was the collection of two millilitres (mL) of blood from peripheral venepuncture (1 mL for blood culture and 1 mL for qPCR), after a careful and exhaustive forearm cleaning with 2% alcoholic chlorhexidine digluconate in 70% ethanol to avoid contamination with bacteria that colonize the skin such as coagulase-negative *Staphylococcus.*

The culture of aerobic and anaerobic organisms was performed in the BACT ALERT 3D, BioMerieux^®^.

Blood samples from non-infected neonates
----------------------------------------

Due to a recommendation of the Research and Ethics Committees from the participating institutions, the collection of blood samples from neonates without infection was not allowed. Therefore, two millilitres of blood (one millilitre for blood culture and one millilitre for quantitative PCR), were collected directly from placenta (cord blood) of 10 full term neonates whose mothers attended the prenatal care and did not present any evidence of infection. Blood collection was performed at the delivery room, by trained nurses, using a sterile specialized kit. The disinfection procedure was performed by a single cleaning step with 70% ethanol. These samples were used as negative controls in the qPCR experiments after checking that the corresponding blood cultures were negative.

DNA extraction
--------------

From this stage, all the manipulations were performed under sterile conditions. The disposable items were autoclaved, and the reagents were filtered through 0.22 μm filters (Merck-Millipore, Billerica, MA, USA). Blood samples were submitted to DNA extraction using the QIAamp DNA mini kit (QIAGEN Inc., Hilden, Germany) with the addition of a specific step to optimize bacterial DNA extraction[@B19] ^,^ [@B20].

Quantitative PCR (qPCR)
-----------------------

The qPCR used in this study has been previously described[@B21]. Briefly, amplifications were performed in an ABI StepOne Real Time PCR System (Applied Biosystems^®^, Foster City, CA, USA). The reagents mixture had a final volume of 25 μL and contained QuantiFast SYBR Green PCR Master Mix (QIAGEN Inc., Hilden, Germany), 0.1 μM of the forward and reverse primers (forward 5′- CAGCTCGTGTCGTGAGATGT-3′ and reverse 5′- CGTAA GGGCCATGATGACT- 3′) and 100 ng of genomic DNA from the neonates with suspected sepsis. Negative controls contained 100 ng of genomic DNA from non-infected infants. An additional negative control containing sterile water (non-template sample) was added to each experiment. Positive samples generated a 150 bp amplification product. All samples were tested in triplicate. Forty cycles of amplification were performed: 95 °C for 5 min followed by 10 cycles of 95 °C for 30 s and 66 °C for 30 s, 10 cycles of 95 °C for 30 s. and 64 °C for 30 s, and 20 cycles of 95 °C for 30 s and 62 °C for 30 s, ending with the melting curve.

The standard qPCR curve was built using cultures of Gram-positive (*Staphylococcus aureus* ATCC 25923 and *Staphylococcus epidermidis* ATCC 12228) and Gram-negative bacteria (*Pseudomonas aeruginosa* ATCC 27853, *Escherichia coli* ATCC 25922 and *Klebsiella pneumoniae* ATCC 700603). The concentration of bacteria equivalent to 0.5 in the McFarland turbidity scale was assumed to correspond to 10[@B8] CFU/mL (CFU = Colony Forming Units) according to Zucol *et al.* [@B20] Then, 10[@B8] CFU in 1.0 mL of saline solution or 10[@B8] CFU/mL[@B22] was centrifuged at 20,817 × g for 10 min at 4 °C, and the pellet was placed in 0.2 mL of whole blood collected in EDTA tubes from a known uninfected individual. Subsequently, these 0.2 mL of blood containing 10[@B8] bacteria had DNA extracted with a commercial kit. At the end of the DNA extraction, the resulting DNA was eluted in 1 mL of Tris-EDTA buffer. This final DNA sample contained 10[@B8] bacteria per mL. Then, the calibration curve of qPCR was constructed beginning with 10 microliters of this DNA solution that corresponds to 10[@B6] bacteria, and serial 1/10 dilutions were made from 10[@B6] bacteria up to 1 CFU. The limit of detection was 1-10[@B1] CFU/ mL (the concentration in which 95% of samples are positive, i.e. 19 tests out of 20)[@B23], regardless of the type of bacteria, Gram-positive or Gram-negative[@B21].

Statistical Analysis
--------------------

To determine the minimum sample size of the study, we assumed that blood cultures would have a sensitivity of 50%, a rather optimistic percentage, and the qPCR a sensitivity of 99%. As the primary outcome of the study is the difference between positivity of blood culture and qPCR, patients were randomized according to blood culture results (blood culture-positive and blood culture-negative subgroups). We also assumed and alpha error of 5% (p \< 0.05) and a beta error of 80% (0.8) and used the applicative [statstodo.com](http://statstodo.com), section of sample size calculation, that resulted in a minimum of 13 samples in each subgroup (ssU = sample size per group for unpaired comparisons). Consequently, the minimum sample size of the study would be 26 cases (13 culture-positive and 13 culture-negative neonates).

Comparisons of the median values of the bacterial load levels between blood culture-positive and blood culturenegative groups were performed using the Mann-Whitney Wilcoxon test, considering significant p-values \< 0.05, in a confidence interval of 95%. The Fisher\'s exact test was used for comparisons of proportions and frequencies when n\<5 and in these cases, no confidence interval could be established. The statistical program used was the GraphPad Prism, version 6.0 (GraphPad Prism Software Inc., CA, USA). Values of p \< 0.05 were considered significant, with a confidence interval of 95%.

RESULTS
=======

Clinical and laboratory data
----------------------------

Regarding the 70 mothers, data on maternal age, type of delivery, number of previous deliveries, if they received prenatal care or not, maternal diagnosis during pregnancy and use of antibiotics during pregnancy are in [Table 1](#t1){ref-type="table"}. The maternal parameters were compared according to neonatal blood culture results, positive or negative, statistical significant difference was found only in the number of maternal diagnosis (urinary tract infection, premature rupture of membranes, placental abruption and hypertensive disorder of pregnancy), more frequent in the culture negative group (p\< 0.001).

###### Maternal and neonatal data in culture-positive and culture-negative groups.

  Variables                                                         Blood culture   *p*-value[§](#TFN2){ref-type="table-fn"}                              
  ----------------------------------------------------------------- --------------- ------------------------------------------ ------- ------- ---------- --------------------------
  Maternal age (years)[\*](#TFN3){ref-type="table-fn"}              19              23                                         25      20      p = 0.12   
  Type of delivery                                                  Vaginal         8                                          5       11      7          p=0.61 CI: −0.15 to 0.31
  Cesarean                                                          9               3                                          20      3                  
  N/A                                                               1               3                                          0       0                  
  No. of previous deliveries                                        1               4                                          4       4       1          p=0.08
  ≥ 2                                                               6               --                                         10      5                  
  N/A                                                               8               7                                          17      4                  
  Prenatal care                                                     Yes             7                                          3       11      5          p=1.00
  No                                                                1               --                                         1       1                  
  N/A                                                               10              8                                          19      4                  
  Maternal diagnosis in pregnancy[\#](#TFN4){ref-type="table-fn"}   Yes             12                                         4       19      7          p\< 0.001
  No                                                                5               4                                          0       0                  
  N/A                                                               1               3                                          12      3                  
  Maternal antibiotics in pregnancy                                 Yes             4                                          2       5       1          p = 0.53
  N/A                                                               14              9                                          26      9                  
  Gestational age (weeks)[\*](#TFN3){ref-type="table-fn"}           32              38,5                                       34      38      p= 0.66    
  Birth weight (grams)[\*](#TFN3){ref-type="table-fn"}              1,795           2,937                                      2,035   3,104   p= 0.36    
  Death                                                             7               1                                          0       0       p\<0.001   
  Neonatal antibiotics                                              AMP+Cpe         6                                          2       1       --         NC
  AMP+GEN                                                           9               5                                          28      9       NC         
  AMP+Cpe+MEM+GEN                                                   1               --                                         --      --      NC         
  AMP+GEN+Cpe                                                       1               1                                          1       --      NC         
  AMP+Cpe+Van+MEM                                                   --              --                                         1       --      NC         
  AMP+GEN+CFL                                                       --              --                                         --      1       NC         
  Cpe+Van+MEM                                                       1               3                                          --      --      NC         

Comparisons were made between culture-positive and culture negative neonates.

*p*-value was calculated by the Fisher\'s exact test when cell counts were \< 5, or by Mann-Whitney Wilcoxon. The confidence interval, CI of 95% was established whenever possible,

median values were considered to analyze maternal age, gestational age and birth weight of neonates at birth; other analyzes considered the number of cases in each category and then comparisons were made between culture-positive and negative groups. N/A: not available; No: number;

maternal diagnosis: urinary tract infection, premature rupture of membranes, placental abruption and hypertensive disorder of pregnancy; NC- not calculated; AMP: Ampicillin; GEN: Gentamicin; Cpe: Cefepime; MEM: Meropenem; VAN: Vancomycin; CFL: cephalexin.

There were 18 preterm and 11 full-term infants (n=29) in the group of culture-positive neonates, and 31 preterm and 10 full-term neonates (n=41) in the culture-negative group ([Table 1](#t1){ref-type="table"}). Considering the neonatal parameters (gestational age, birth weight, deaths), the only statistical significant difference was found with respect to deaths (p\< 0.001), as the total 8 deaths occurred in the culture-positive group, in 7 preterm and 1 full-term infant ([Table 1](#t1){ref-type="table"}).

All neonates, irrespective of the group (culture-positive or culture-negative) received antibiotics, varying from ampicillin and gentamicin (first choice) to vancomycin, cefepime and meropenem, for periods of 1 to 3 weeks ([Table 1](#t1){ref-type="table"}).

On admission to the NICU, the median age of infants was 9 days old (minimum 02 - maximum 15) in either culture-positive or negative neonates.

Among the 29 blood culture-positive cases, there were 26 Gram-positive bacteria: 19 coagulase-negative *Staphylococcus,* 2 *Staphylococcus aureus,* 2 *Streptococcus agalactiae,* 1 *Streptococcus pneumoniae,* 1 *Streptococcus viridans* and 1 *Lysteria monocytogenes.* In addition, three Gram-negative bacteria were found: 2 *Klebsiella pneumoniae* and 1 *Pseudomonas aeruginosa*.

The most frequent clinical manifestations were respiratory distress and mild to moderate perinatal asphyxia, while the most common laboratory abnormalities were leukopenia, neutrophilia, thrombocytopenia, and CRP \> 10 mg/L. It was noteworthy that the culture-positive and -negative groups had similar frequencies of clinical and laboratory abnormalities ([Table 2](#t2){ref-type="table"}).

###### Clinical and laboratory parameters of the 29 blood culture-positive and the 41 blood culture-negative neonates.

  Clinical and laboratory parameters                     Culture-positive N=29 (%)   Culture-negative N=41 (%)   *p*-value[\#](#TFN7){ref-type="table-fn"} *p*\<0.05 (95% CI)
  ------------------------------------------------------ --------------------------- --------------------------- --------------------------------------------------------------
  Respiratory distress[\*](#TFN5){ref-type="table-fn"}   29 (100)                    36 (88)                     0.730
  Perinatal asphyxia[§](#TFN6){ref-type="table-fn"}      21 (72)                     27 (65)                     0.618 (CI −0.163 to 0.314)
  Leukopenia                                             17 (58)                     16 (39)                     0.805 (CI −0.176 to 0.292)
  Neutrophilia                                           19 (65)                     22 (54)                     1.000 (CI −0.212 to 0.250)
  Thrombocytopenia                                       16 (64)                     24 (58)                     0.225 (CI −0.006 to 0.397)
  CRP (\> 10 mg/L)                                       18 (62)                     20 (49)                     1.000 (CI −0.226 to 0.235)

The respiratory distress syndrome considered fast breathing, chest wall retractions, expiratory grunting, nasal flaring, cyanosis, lethargy, irregular breathing and apnea.

Perinatal asphyxia considered cyanosis, perfusion abnormalities, unresponsiveness, decreased muscle tone (hypotonia) and increased respiratory effort. All signs and symptoms should have been transient, not characterizing severe asphyxia. CRP (C reactive protein).

*p*-value was calculated using the Fisher\'s exact test. Confidence interval of 95% was established whenever possible.

Among the 29 blood culture-positive neonates, 29 presented positive qPCR (100%). Considering the 41 culture-negative cases, 35 (85.4%) presented positive and six (14.6%) had negative qPCR. Clinical and laboratory data of the six cases with negative blood culture and qPCR results are in [Table 3](#t3){ref-type="table"}.

###### Clinical and laboratory data of the six cases of neonatal sepsis included in the study that showed negative results by blood culture and qPCR.

  Case   Delivery           GA (weeks)   BW (g)   Apgar score   Maternal illness   Maternal antibiotics   PROM (hours)   Neonatal diagnoses                                      Laboratory abnormalities
  ------ ------------------ ------------ -------- ------------- ------------------ ---------------------- -------------- ------------------------------------------------------- -----------------------------------------------
  6T     Vaginal            39           2,265    0/8           UTI                AMP                    12             Respiratory distress; Perinatal asphyxia                Neutrophilia, Leukopenia, Thrombocytopenia
  63T    Cesarean section   39           3,460    6/8           CPD                NO                     NO             Respiratory distress; Perinatal asphyxia; MAS           Neutrophilia, Thrombocytopenia; Increased CRP
  47PT   Cesarean section   36           2,470    8/9           NO                 NO                     NO             Prematurity, Severe lethargy;                           Neutrophilia, Thrombocytopenia
  51PT   Cesarean section   35           1,865    5/8           NO                 NO                     NO             Prematurity, Respiratory distress; Perinatal asphyxia   Leukocytosis, Neutrophilia; Increased CRP
  60PT   Vaginal            36           2,066    6/8           NO                 AMP                    4              Prematurity, Respiratory distress; Perinatal asphyxia   Leukopenia, Thrombocytopenia; Increased CRP
  67PT   Cesarean section   34           1465     8/9           NO                 NO                     NO             Prematurity, Respiratory distress;                      Neutrophilia, Thrombocytopenia; Increased CRP

T: full-term (37-42 weeks of gestation); PT: preterm infant (\< 37 weeks of gestation); GA: Gestational age; BW: Birth Weight; Apgar score was recorded in the 1^st^/5^th^ minute of life; PROM - Premature rupture of membranes; UTI - Urinary tract infection; CPD - Cephalopelvic disproportion; AMP: Ampicillin; MAS - Meconium aspiration syndrome; Increased CRP (C reactive protein) \> 10 mg/L.

The comparison between the median of bacterial load levels in the group of blood culture-positive infants (40.84 CFU/mL; minimum 6.6 - maximum 120.90) and blood culture-negative ones (25.13 CFU/mL; minimum 1.28 - maximum 41,419) found a statistically significant difference (Mann-Whitney, p = 0.013; [Figure 1](#f1){ref-type="fig"}). Nevertheless, qPCR did not find higher bacterial load levels in these 8 neonates who died when they were compared with the other 21 infants belonging to the culture-positive group (Mann-Whitney Wilcoxon, p= 0.59).

![Comparison of the bacterial load (CFU/mL) assessed by qPCR between the culture-positive (n=29) and negative groups (n=35). Mann-Whitney test, p = 0.013. The bars represent the median values. CFU - Colony forming units; mL - millilitre; qPCR - quantitative Real Time PCR.](1678-9946-rimtsp-60-S1678-9946201860061-gf01){#f1}

Culture-positive and culture-negative groups were arbitrarily divided into five subgroups according to their bacterial load levels ([Table 4](#t4){ref-type="table"}). Only in the range of 50-10[@B2] bacteria/CFU there were significantly more cases in the culture-positive group (p=0.034).

###### Bacterial load levels determined by qPCR arbitrarily divided into five groups according to load levels, in blood culturepositive and culture-negative cases.

  qPCR Bacterial load (CFU/mL)   Culture     *p*-value^\#^   
  ------------------------------ ----------- --------------- ------------------------------------
  1 to 10                        2 (6.9)     3 (8.6)         p = 0.441
  11 to 30                       7 (24.1)    17 (48.6)       p = 0.115 (CI 95% −0.022 to 0.486)
  31 to 50                       11 (38.0)   11 (31.4)       p = 0.593 (CI 95% −0.154 to 0.365)
  51 to 10[@B2]                  8 (27.6)    2 (5.7)         p = 0.034
  \> 10[@B2]                     1 (3.4)     2 (5.7)         p = 1.000
  **Total**                      **29**      **35**          **-**

qPCR - quantitative Real Time PCR; CFU - Colony forming units; mL - millilitre; No - Number; ^\#^p-value was calculated using the Fisher\'s exact test and the confidence interval of 95% was calculated whenever possible.

Regarding the culture-positive group, the full-term infant in whom a *Streptococcus agalactiae* was isolated, had the highest bacterial load (120.9 CFU/mL). This infant received ampicillin, gentamycin and cefepime for two weeks and evolved favourably.

In the culture-negative group, there were two preterm infants with bacterial load levels above 10[@B2] CFU/mL. The mother of the first infant had sepsis and received broad-spectrum antibiotics, with a favourable outcome. Unfortunately, no information could be retrieved on the isolation of bacteria from her blood cultures. The bacterial load of this neonate was 41,419 CFU/mL. In the second case, no maternal morbidity was reported and the bacterial load of the infant was 452 CFU/mL. These two neonates responded favourably after treatment with ampicillin and gentamicin (first choice of antibiotics) for two weeks.

DISCUSSION
==========

As far as we know, this is the first study in which bacterial load levels were assessed through qPCR and were compared between a group of blood culture-positive neonates and a group of blood culture-negative ones. A better laboratory characterization of blood culture-negative infants with sepsis is relevant because neonates with culture-negative sepsis present higher neurodevelopmental impairment rates when compared to non-infected infants[@B10], receive antibiotics, therefore increasing hospital costs, and they remain hospitalized for prolonged periods, raising the risks of infections associated with health care.

Regarding maternal and neonatal characteristics, the only difference found between culture-positive and the culture-negative groups was the number of maternal diagnosis during pregnancy ([Table 1](#t1){ref-type="table"}) higher in the culturenegative group. However, given that the information on maternal treatment is lacking in the majority of cases, in both groups, this difference may not reflect the reality.

In respect to the neonates ([Table 1](#t1){ref-type="table"}), the gestational age, birth weight and number of deaths in the culture-positive and negative groups, the only significant difference was found in the number of deaths, as the total of 8 deaths of the study occurred in the culture positive group (7 preterm and 1 full-term infant). Albeit this difference, considering clinical and laboratory abnormalities such as respiratory distress, perinatal asphyxia, leukopenia, neutrophilia, thrombocytopenia and increased CRP, ([Table 2](#t2){ref-type="table"}) culturepositive and culture-negative neonates did not differ, reinforcing that only neonates with suspicion of sepsis were included in both groups.

In this study, the percentage of positive blood cultures was 41.4%, a relatively high percentage in comparison with lower rates reported in other neonatal studies[@B12] ^,^ [@B13] ^,^ [@B24] ^--^ [@B29]. However, the 70 recruited cases had consistent clinical and laboratory evidence of infection ([Table 2](#t2){ref-type="table"}) and the participant neonatal intensive care units are reference centers in their communities, probably concentrating the most severe cases.

Regarding the etiological agents, blood cultures indicated a predominance of coagulase-negative *Staphylococcus* among culture-positive neonates (19/29) that were also the most frequent in the group of eight infants who evolved to death (5/8) corroborating that this bacterium was the leading cause of infections in this study, as well as in other countries[@B30] ^--^ [@B34]. It was also noteworthy that neonatal infections took place after the first days of life with a median age of infants on admission to the NICUs of nine days in both groups, characterizing late-onset infections. In this sense, the predominance of coagulase-negative *Staphylococcus* in blood cultures is in agreement with the type of infection.

Coagulase-negative *Staphylococcus* was detected in blood cultures of 19/29 culture-positive neonates and blood sampling was performed on admission at the NICUs. According to the medical records, a second blood culture was not performed to confirm whether infections were true or due to skin contamination, probably because these neonates were critically ill at least during the first days of hospitalization, according to clinical signs and laboratory abnormalities ([Table 2](#t2){ref-type="table"}).

Another possibility that should not be overlooked, is the existence of bacteria detected only by qPCR, that belong to a group that has not yet been isolated in cultures, but are potentially pathogenic, especially to preterm infants[@B35]. Through DNA sequencing coupled to qPCR it would be possible to determine whether these bacteria are the same found in culture-positive cases. These data can be relevant to medical assistance but, in this study, we did not analyse amplification products because we were focused on the study of bacterial load levels and whether they could provide information to increase the understanding of culturenegative neonatal sepsis.

In a previous study, our research group has shown that qPCR is more sensitive than blood cultures and has a high negative predictive value. As a consequence, when this molecular test is negative together with blood culture, qPCR could help to rule out the presence of infection, shortening both, the treatment and the length of hospital stay[@B21]. Unfortunately, it does not seem that we could use this reasoning to explain the six neonates with negative qPCR and blood cultures, among the 41 culture-negative cases ([Table 3](#t3){ref-type="table"}). Two neonates had mothers who received antibiotics prior to delivery, reducing the sensitivity of neonatal blood cultures, and all of the six infants had severe clinical and laboratory abnormalities (respiratory distress and perinatal asphyxia, thrombocytopenia, leukopenia or leucocytosis, increased CRP) at least during the first few days after NICU admission. When neonates are critically ill, physicians usually prioritize life support exams, such as blood gases and electrolytes, to the detriment of other exams, so that the volume of blood placed into culture bottles is the remaining amount, which is frequently insufficient and more prone to contamination due to excessive handling. Inadequate blood volumes inserted into culture bottles are the main cause of blood cultures negativity[@B4] ^,^ [@B9] ^,^ [@B36]. In the present study, it is possible to guarantee that at least 1 mL of blood was used to perform blood cultures so that other causes have to be raised to explain why blood cultures fail to identify neonatal sepsis in cases with bacterial load levels above 1-10 CFU/mL[@B4] ^,^ [@B6] ^,^ [@B7] ^,^ [@B9] ^,^ [@B36] ^,^ [@B37].

According to the literature, if at least 1 mL of blood is inserted into culture bottles[@B4] ^,^ [@B6], the automated culture systems used nowadays should be able to detect positive results in the majority of neonates investigated in the present study, even in the culture-negative group, as 31/35 culturenegative neonates had bacterial load levels \< 50 CFU/mL. The only exceptions would be five infants, two in the culture-positive and three in the culture-negative group, in whom bacterial load levels were 1-10 CFU/mL. ([Table 4](#t4){ref-type="table"}).

Significantly higher bacterial load levels were observed in the culture-positive group in relation to the culturenegative one ([Figure 1](#f1){ref-type="fig"}), and these differences were found without the exclusion of the two neonates with bacterial load levels \> 10[@B2] CFU/ mL in the culture-negative group (outliers), otherwise the differences would be even greater.

It is true that the ideal blood volume to ensure reliability of negative blood culture results is still a topic of debate. Schelonka *et al*.[@B4] estimated that a 0.5 mL inoculum of blood inserted into culture media is inadequate for sensitive and timely detection of bacteremia when the colony count is less than 4 CFU/mL, requiring 1.0-2.0 milliliters of blood to increase bacterial recovery.

Kellogg *at al*.[@B5] claimed that bacteremia is often very low in infants from birth to two months of age and estimated the need of culturing up to 6 mL of blood, representing around 4.5% of an infant\'s total blood volume to achieve an efficient detection of pathogens.

Connell *et al*.[@B6] studied blood volumes submitted for culture in routine clinical practice of pediatric units and established the proportion of blood cultures with a blood volume inadequate for reliable detection of bacteremia. They showed that a negative blood culture result is inevitable for a large proportion of blood cultures due to submission of inadequate blood volume, but they did not state what blood volumes they were referring to as ideal. In that study, even after an educational intervention, nearly 50% of blood cultures remained inadequate and this percentage was higher in neonatal cases.

In view of the bacterial load levels found in the two groups and because at least 1 mL of blood was inserted into culture bottles in the present study, we believe that blood volumes of 1 mL are not always sufficient to detect bacteraemia in neonates, not only in the range of 1-10[@B1] CFU/mL, but also in higher concentrations. In the context of this research, it was possible to control the variable represented by the volume of blood, but in clinical practice, this information is not available when medical notes are consulted, however, given its relevance, paediatric units, especially the neonatal ones, should consider the information of blood volumes placed in culture bottles as mandatory.

Other parameters such as the number of blood cultures performed per infection episode, blood collection performed in only one site, inadequate blood collection technique, delayed entry of culture bottles into blood culture machines[@B7] ^--^ [@B9], despite the undeniable difficulties, should also be controlled.

The present study faced limitations such as the impossibility to perform peripheral blood collection from a number of healthy uninfected neonates to perform blood cultures and qPCR, to be able to compare these results with the ones from the culture-positive and negative groups, due to ethical issues. In addition, more collection times, for instance, 48-72 h after the beginning of antibiotics therapy, one week and two weeks afterwards, at each antibiotic regimen change and immediately before NICUs discharge, analyzing blood cultures and qPCRs in parallel, would be much informative. It would also be interesting to analyze full term and preterm neonates separately, as well as early neonatal sepsis besides late infections. In future studies, subgroups of full-term and preterm neonates, randomized by gestational age, birth weight, onset of symptomatology, and according to the type of isolated bacteria (Gram-positive and Gram-negative) will provide relevant information.

In conclusion, the present study has shown that blood culture-negative neonates do have lower bacteria load levels in their bloodstream when compared to blood culturepositive infants in the context of neonatal sepsis.
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